Jove
Visualize
Contact Us

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hematemesis; a study of underlying causes.

Gastroenterology·2010
Same author

Surgical treatment of peptic ulcer; recent experience at Los Angeles General Hospital.

Archives of surgery (Chicago, Ill. : 1920)·2010
Same author

The Influence of Tuberculin upon the Production of Antibodies.

The Journal of medical research·2009
Same author

Levels of Ly-49 receptor expression are determined by the frequency of interactions with MHC ligands: evidence against receptor calibration to a "useful" level.

Journal of immunology (Baltimore, Md. : 1950)·1999
Same author

Altered expression of Ly-49 receptors on NK cells developing in mixed allogeneic bone marrow chimeras.

International immunology·1999
Same author

Hematopoietic chimerism and tolerance of T cells, B cells, and NK cells.

Transplantation proceedings·1998
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 3, 2026

Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells
14:37

Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells

Published on: November 1, 2017

Embryonic stem cell-derived hematopoietic stem cells: challenges in development, differentiation, and immunogenicity.

H L Thompson1, J O Manilay

  • 1Quantitative and Systems Biology Graduate Program, School of Natural Sciences, 5200 North Lake Road, Merced, CA 95343, USA.

Current Topics in Medicinal Chemistry
|March 31, 2011
PubMed
Summary

Embryonic stem cells offer therapeutic potential but face challenges like immune rejection. Inducing mixed hematopoietic chimerism may promote tolerance for ESC-derived therapies.

More Related Videos

Derivation of Hematopoietic Stem Cells from Murine Embryonic Stem Cells
22:06

Derivation of Hematopoietic Stem Cells from Murine Embryonic Stem Cells

Published on: February 25, 2007

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
08:53

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

Related Experiment Videos

Last Updated: Jun 3, 2026

Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells
14:37

Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells

Published on: November 1, 2017

Derivation of Hematopoietic Stem Cells from Murine Embryonic Stem Cells
22:06

Derivation of Hematopoietic Stem Cells from Murine Embryonic Stem Cells

Published on: February 25, 2007

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
08:53

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

Area of Science:

  • Regenerative Medicine
  • Immunology
  • Stem Cell Biology

Background:

  • Embryonic stem cells (ESCs) possess pluripotency, enabling differentiation into various cell types for therapeutic applications.
  • ESC-derived tissues hold promise for treating degenerative diseases and organ damage.
  • Significant challenges hinder clinical translation, including inefficient tissue production, poor integration, and immune rejection.

Purpose of the Study:

  • To review challenges in developing transplantable ESC-derived hematopoietic stem cells.
  • To discuss the in vivo differentiation fate of ESC-derived hematopoietic progenitors.
  • To suggest methods for predicting and preventing immunogenicity of ESC-derived hematopoietic cells.

Main Methods:

  • Review of existing literature on ESC differentiation and transplantation.
  • Analysis of mechanisms underlying immune tolerance induction via hematopoietic chimerism.
  • Discussion of strategies for assessing immunogenicity of ESC-derived cells.

Main Results:

  • ESC differentiation can yield hematopoietic progenitors, but challenges remain for generating bona fide hematopoietic stem cells.
  • Mixed hematopoietic chimerism in mouse models demonstrates potential for inducing tolerance to allogeneic ESC-derived tissues.
  • Predictive assays for immunogenicity could guide the selection of ESC-derived hematopoietic populations for transplantation.

Conclusions:

  • Overcoming challenges in ESC differentiation and immunogenicity is crucial for realizing therapeutic potential.
  • Mixed hematopoietic chimerism offers a promising strategy for immune tolerance in ESC-based therapies.
  • Developing methods to predict and mitigate immune rejection is essential for successful clinical application of ESC-derived therapies.